Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Frontage Holdings Corp. ( (HK:1521) ) has provided an announcement.
Frontage Holdings Corporation has updated the terms of reference for its Nomination Committee, which was originally established in 2018. The committee will consist of at least three non-executive directors, with a majority being independent and at least one member of a different gender, reflecting the company’s commitment to diversity and governance.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
More about Frontage Holdings Corp.
Frontage Holdings Corporation operates within the pharmaceutical and biotechnology industry, providing research and development services to support drug discovery and development processes.
Average Trading Volume: 270,962
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$2.3B
For a thorough assessment of 1521 stock, go to TipRanks’ Stock Analysis page.